These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16415708

  • 21. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC, Schulz SC, Detke HC, Tanaka Y, Zhao F, Lin D, Deberdt W, Kryzhanovskaya L, Corya S.
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [Abstract] [Full Text] [Related]

  • 22. Topiramate reduced aggression in female patients with borderline personality disorder.
    Nickel M.
    Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):432-3. PubMed ID: 17902007
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL, Arnold LM, Shapira NA, Keck PE, Rosenthal NR, Karim MR, Kamin M, Hudson JI.
    Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
    [Abstract] [Full Text] [Related]

  • 29. Oxcarbazepine in the treatment of borderline personality disorder: a pilot study.
    Bellino S, Paradiso E, Bogetto F.
    J Clin Psychiatry; 2005 Sep; 66(9):1111-5. PubMed ID: 16187767
    [Abstract] [Full Text] [Related]

  • 30. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A, Pani A.
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO.
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF, Khan A, Lane R, Olson WH.
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [Abstract] [Full Text] [Related]

  • 39. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H, Chouicha K, Montovany A, Callahan S.
    Encephale; 2001 Feb; 27(2):120-7. PubMed ID: 11407263
    [Abstract] [Full Text] [Related]

  • 40. Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.
    Teicher MH, Glod CA, Aaronson ST, Gunter PA, Schatzberg AF, Cole JO.
    Psychopharmacol Bull; 1989 Feb; 25(4):535-49. PubMed ID: 2631134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.